About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new ...

Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19 ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

The proposed merger would create a new ophthalmic company that combines two FDA-approved technologies: Betaliq's EyeSol ® water-free drug delivery technology for use in glaucoma, and Eyenovia's ...

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...

Non-executive directors are supposed to provide a company’s management with independent perspectives. Does the experience ...

‘It is absolutely illegal’: FTC Commissioner speaks out after being fired by Trump Blitzer asks former Justice Stephen Breyer ...

Thousands of Food and Drug Administration employees are returning to the office to find overflowing parking lots, cramped ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

President Trump said his administration will release 80,000 files on the assassination of president Kennedy on Tuesday.